Ken Kaito

786 total citations
45 papers, 584 citations indexed

About

Ken Kaito is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Ken Kaito has authored 45 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 14 papers in Immunology and 8 papers in Genetics. Recurrent topics in Ken Kaito's work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (6 papers). Ken Kaito is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (6 papers). Ken Kaito collaborates with scholars based in Japan and United Kingdom. Ken Kaito's co-authors include Masayuki Kobayashi, Hiroko Otsubo, Noriko Usui, Miyuki Yoshida, Hidekazu Masuoka, Kaichi Nishiwaki, Yoji Ogasawara, Tatsuo Hosoya, Michiko Kobayashi and Masahiro Yoshida and has published in prestigious journals such as British Journal of Haematology, European Journal Of Haematology and Leukemia Research.

In The Last Decade

Ken Kaito

45 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Kaito Japan 10 358 170 133 106 83 45 584
Behrouz Mansouri Taleghani Switzerland 18 593 1.7× 170 1.0× 149 1.1× 52 0.5× 177 2.1× 75 1.1k
Nilgün Sayınalp Türkiye 16 511 1.4× 137 0.8× 55 0.4× 102 1.0× 203 2.4× 84 875
Oren Pasvolsky Israel 14 337 0.9× 137 0.8× 127 1.0× 68 0.6× 143 1.7× 64 609
Andreas Holbro Switzerland 18 468 1.3× 144 0.8× 160 1.2× 40 0.4× 152 1.8× 70 801
Ernesto de Meis Brazil 12 228 0.6× 94 0.6× 46 0.3× 74 0.7× 48 0.6× 21 484
Jonathan P. Kerr United Kingdom 8 256 0.7× 205 1.2× 212 1.6× 24 0.2× 173 2.1× 11 818
Hyun-Sook Chi South Korea 13 225 0.6× 101 0.6× 97 0.7× 80 0.8× 68 0.8× 33 503
John E. Curtis Canada 14 226 0.6× 127 0.7× 127 1.0× 27 0.3× 62 0.7× 18 605
Prentice Hg United Kingdom 14 354 1.0× 177 1.0× 145 1.1× 31 0.3× 68 0.8× 20 622
Bertrand Lioger France 12 171 0.5× 171 1.0× 80 0.6× 41 0.4× 115 1.4× 41 513

Countries citing papers authored by Ken Kaito

Since Specialization
Citations

This map shows the geographic impact of Ken Kaito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kaito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kaito more than expected).

Fields of papers citing papers by Ken Kaito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Kaito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kaito. The network helps show where Ken Kaito may publish in the future.

Co-authorship network of co-authors of Ken Kaito

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Kaito. A scholar is included among the top collaborators of Ken Kaito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Kaito. Ken Kaito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyama, Masaharu, et al.. (2018). NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells. Leukemia Research. 74. 57–63. 13 indexed citations
2.
Kaito, Ken, et al.. (2007). Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System. International Journal of Hematology. 85(2). 128–131. 2 indexed citations
3.
Kaito, Ken, Hiroko Otsubo, Nobuaki Dobashi, Noriko Usui, & Masayuki Kobayashi. (2005). CD2 + Tetraploid Acute Promyelocytic Leukemia Variant with Double (15;17) Translocations. International Journal of Hematology. 81(1). 29–31. 3 indexed citations
4.
Usui, Noriko, Shingo Yano, Osamu Asai, et al.. (2005). Long-Term Follow-up High-Dose Chemotherapy (Drug-Only Program) Followed by Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas. Clinical Lymphoma. 6(1). 31–36. 5 indexed citations
5.
6.
Kaito, Ken, et al.. (2003). Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome. Annals of Hematology. 82(11). 699–701. 9 indexed citations
7.
Kaito, Ken, et al.. (2003). Adhesion molecule expression by bone marrow CD34-positive cells in aplastic anemia before and after immunosuppressive therapy. Clinical & Laboratory Haematology. 25(6). 393–396. 1 indexed citations
8.
Sugimori, Chiharu, Shinji Nakao, & Ken Kaito. (2003). Persistent Remission after Immunosuppressive Therapy of Hairy Cell Leukemia Mimicking Aplastic Anemia: Two Case Reports. International Journal of Hematology. 77(4). 391–394. 4 indexed citations
9.
Kaito, Ken, et al.. (2003). Secondary polycythemia as a paraneoplastic syndrome of testicular seminoma. Annals of Hematology. 83(1). 55–57. 6 indexed citations
10.
Usui, Noriko, Nobuaki Dobashi, Osamu Asai, et al.. (2002). Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia. International Journal of Hematology. 76(5). 436–445. 4 indexed citations
11.
Otsubo, Hiroko, et al.. (2002). Successful Immunosuppressive Therapy With Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ—Positive T-Lymphocytes. International Journal of Hematology. 75(3). 285–288. 2 indexed citations
12.
Tamaru, Jun‐ichi, et al.. (2001). Primary Central Nervous System Lymphomas Express Vh Genes with Intermediate to High Somatic Mutations. Leukemia & lymphoma. 41(3-4). 377–385. 13 indexed citations
13.
14.
Kaito, Ken, Masayuki Kobayashi, Hidekazu Masuoka, et al.. (1998). Long‐term administration of G‐CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults. British Journal of Haematology. 103(2). 297–303. 64 indexed citations
15.
Kaito, Ken, Mikio Kobayashi, Masaru Sakamoto, et al.. (1998). Combination Chemotherapy with G-CSF, M-CSF and EPO: Successful Treatment for Acute Myelogenous Leukemia without Blood Transfusion at Lower Medical Costs. Acta Haematologica. 100(1). 57–60. 6 indexed citations
16.
Kaito, Ken, Michiko Kobayashi, Yoji Ogasawara, et al.. (1997). Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. European Journal Of Haematology. 59(4). 247–253. 116 indexed citations
17.
Tsuchida, Hiroki, K Hamaguchi, Ken Kaito, et al.. (1995). [A case of nephrotic syndrome mimicking membranoproliferative glomerulonephritis (MPGN) and associated with reactive hemophagocytic syndrome after renal death].. PubMed. 37(4). 253–7. 1 indexed citations
18.
Kaito, Ken, Yoji Ogasawara, Akira Saeki, et al.. (1995). [RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF].. PubMed. 36(4). 365–70. 3 indexed citations
19.
Kobayashi, Masayuki, Mayumi Yoshida, Ken Kaito, et al.. (1992). [High-dose cepharanthin therapy of idiopathic thrombocytopenic purpura].. PubMed. 33(3). 405–7. 11 indexed citations
20.
Kaito, Ken, et al.. (1990). Clinical Courses and Pathological Findings in Two Gay Male Patients with Acquired Immunodeficiency Syndrome infected in Japan. Kansenshogaku zasshi. 64(2). 210–217. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Behrouz Mansouri Taleghani Breakdown of academic impact, for papers by Nilgün Sayınalp Breakdown of academic impact, for papers by Oren Pasvolsky Breakdown of academic impact, for papers by Andreas Holbro Breakdown of academic impact, for papers by Ernesto de Meis Breakdown of academic impact, for papers by Jonathan P. Kerr Breakdown of academic impact, for papers by Hyun-Sook Chi Breakdown of academic impact, for papers by John E. Curtis Breakdown of academic impact, for papers by Prentice Hg Breakdown of academic impact, for papers by Bertrand Lioger
Rankless by CCL
2026